C₂₂₁H₃₆₆N₇₂O₆₇S · 5135.79 g/mol
Tesamorelin
Tesamorelin is a 44-amino-acid synthetic analogue of growth hormone-releasing hormone (GHRH), modified with an N-terminal trans-3-hexenoyl group that protects against dipeptidyl peptidase-IV cleavage. It is the only GHRH analogue approved by the FDA — currently indicated for HIV-associated lipodystrophy — and has been studied extensively in clinical and preclinical research for effects on visceral adipose tissue, lipid metabolism, and IGF-1 levels.
Research Areas
- •Visceral adipose tissue
- •GHRH receptor activation
- •IGF-1 modulation
- •Lipid metabolism
Molecular Specifications
Molecular Formula
C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight
5135.79 g/mol
Purity
≥98.0%
Select Size
Prices are subject to change. Final pricing will be confirmed at checkout.
Certificates of Analysis
Current batch test results for Tesamorelin. Click any row to download the full lab report PDF — third-party HPLC, USP<85> endotoxin, and USP<71> microbial testing.
You May Also Like
CJC-1295 No DAC (Mod GRF 1-29)
Short-acting GHRH analogue (Modified GRF 1-29) for growth hormone research.
From $51.99
View DetailsCJC-1295 No DAC / Ipamorelin Blend
Classic GH-stacking blend — Mod GRF 1-29 + Ipamorelin in a single vial.
From $64.99
View DetailsPT-141 (Bremelanotide)
Melanocortin receptor agonist for research applications.
From $61.99
View Details